Clinical Trials Logo

Allergy;Food clinical trials

View clinical trials related to Allergy;Food.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06167564 Not yet recruiting - Allergy Clinical Trials

Allergy Diagnostic Test Based on Microchip Technology

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a microarray-based diagnostic test system for the determination of allergen specific IgE in human blood serum.

NCT ID: NCT05826405 Not yet recruiting - Allergy;Food Clinical Trials

Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)

CAJESITO
Start date: May 10, 2023
Phase:
Study type: Observational

The objectives of the CAJESITO study are (i) to assess the tolerance of oral cashew nut immunotherapy, by describing the frequency and severity of allergic reactions during oral cashew nut immunotherapy and (ii )to assess the risk factors for severe allergic reactions during oral cashew nut immunotherapy (predictive factors, associated factors.

NCT ID: NCT05407012 Not yet recruiting - Allergy;Food Clinical Trials

TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel Food Processing and Skin Care Adaptations

TRANS-FOODS
Start date: November 13, 2023
Phase: N/A
Study type: Interventional

This project aims to study the immune responses to peanut allergen in those with a skin barrier defect with and without skin massage, specifically it aims to: 1. Establish if peanut allergen components can pass into human skin through regular massage using the peanut protein-containing extract. 2. Clarify whether this effect is amplified in those with an impaired skin barrier (AD and dry skin vs healthy controls). 3. Assess whether peanut protein components can be detected in interstitial skin fluid (ISF) using a suction device. 4. Test whether peanut protein components present in ISF are able to induce activation of basophils in blood of peanut allergic donors. 5. Assess whether the transcutaneous uptake of peanut protein can be reduced by the prior use of a barrier enhancing cream.

NCT ID: NCT04828317 Not yet recruiting - Allergy;Food Clinical Trials

Alpha-gal Pork Challenge

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

This study is investigating the hypothesis that alpha-gal is responsible for the gastrointestinal symptoms that occur in some alpha-gal syndrome subjects following the consumption of mammalian meat. This will be tested by comparing symptoms and immune responses in subjects with alpha-gal syndrome following consumption of "wild-type" pork (which contains alpha-gal) versus consumption of a novel pork product which has been genetically modified to lack alpha-gal (GalSafe pork from Revivicor Inc.).

NCT ID: NCT04329078 Not yet recruiting - Allergy;Food Clinical Trials

Relevance of Sensitization to Legumes in Children Allergic to Peanut

Start date: April 1, 2020
Phase:
Study type: Observational

The objectives of this study are to determine in children allergic to peanut (i) the prevalence of sensitization to other legumes, (ii) the prevalence of allergy to each legume in patients who are sensitized to it (iii ) the severity of the allergy to legumes other than peanut